A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia
Clinical trial NCT05463770 · COMPLETED
Trial details
- NCT number
- NCT05463770
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-30
- Primary completion
- 2023-08-22
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.